Micro Labs Limited — Moxifloxacin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Moxifloxacin · $2.3M export value · DGFT Verified
Micro Labs Limited is the #4 Indian exporter of Moxifloxacin with $2.3M in export value and 86 verified shipments. Micro Labs Limited holds a 7.0% market share in Moxifloxacin exports across 14 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Moxifloxacin Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Moxifloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| THAILAND | $693.8K | 15 | 35.3% |
| NIGERIA | $411.6K | 10 | 21.0% |
| GERMANY | $326.7K | 19 | 16.6% |
| UNITED KINGDOM | $115.8K | 3 | 5.9% |
| UNITED ARAB EMIRATES | $100.0K | 2 | 5.1% |
| MEXICO | $80.2K | 4 | 4.1% |
| DOMINICAN REPUBLIC | $50.0K | 1 | 2.5% |
| MADAGASCAR | $47.9K | 22 | 2.4% |
| KENYA | $38.4K | 6 | 2.0% |
| NETHERLANDS | $35.5K | 2 | 1.8% |
Micro Labs Limited exports Moxifloxacin to 15 countries. The largest destination is THAILAND accounting for 35.3% of Micro Labs Limited's Moxifloxacin shipments, followed by NIGERIA (21.0%) and GERMANY (16.6%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Moxifloxacin from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MAXIM INTER-CORPORATION LTD | THAILAND | $290.5K | 6 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $284.0K | 6 |
| MAXIM INTER-CORPORATION LTD. | THAILAND | $253.3K | 6 |
| MSK PHARMALOGISTIC GMBH | GERMANY | $214.7K | 11 |
| MAXIM INTER-CORPORATION LIMITED | THAILAND | $150.0K | 3 |
| MICROSYNERGY PHARMACEUTICALS FZCO | UNITED ARAB EMIRATES | $100.0K | 2 |
| COIMPORTEX SERVICIOS ADUANALES S.C. | MEXICO | $80.2K | 4 |
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $79.0K | 2 |
| MICRO NOVA PHARMACEUTICALS IND. LTD | NIGERIA | $77.5K | 3 |
| MSK PHARMALOGISTIC GMBH. | GERMANY | $62.0K | 7 |
Micro Labs Limited supplies Moxifloxacin to 31 buyers globally. The largest buyer is MAXIM INTER-CORPORATION LTD (THAILAND), followed by MICRO NOVA PHARMACEUTICALS IND (NIGERIA) and MAXIM INTER-CORPORATION LTD. (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Moxifloxacin Export Value and How Much Does Micro Labs Limited Contribute?
India exported $14.3M worth of Moxifloxacin through 2,413 shipments from 336 suppliers to 137 countries, serving 731 buyers globally. Micro Labs Limited contributes $2.3M to this total, accounting for 7.0% of India's Moxifloxacin exports. Micro Labs Limited ships Moxifloxacin to 15 countries through 31 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Moxifloxacin Exports?
Micro Labs Limited's average Moxifloxacin shipment value is $26.5K per consignment, based on 86 shipments totaling $2.3M. The largest destination is THAILAND (35.3% of Micro Labs Limited's Moxifloxacin exports).
How Does Micro Labs Limited Compare to Other Indian Moxifloxacin Exporters?
Micro Labs Limited ranks #4 among 336 Indian Moxifloxacin exporters with a 7.0% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($2.3M), MICRO LABS LIMITED ($2.3M), EUGIA PHARMA SPECIALITIES LIMITED ($1.9M). Micro Labs Limited processed 86 shipments to 14 destination countries.
What Moxifloxacin Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MOXI MAC (MOXIFLOXACIN OPHTHALMIC SOLUTI | $195.4K | 5 |
| MICROMOX 400 (MOXIFLOXACIN 400MG TABLETS | $134.0K | 3 |
| MOXI MAC (MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% w/v) (5ML) - TAX INVOICE NO:714201272 DT: 20.03.2025 | $100.0K | 2 |
| MOXI-MAC (MOXIFLOXACIN OPHTHALMIC SOLUTI | $98.4K | 2 |
| MICROMOX EYE DROPS (MOXIFLOXACIN OPHTHALMIC SOLUTION 0% W/V)(5ML)(QTY-71550)PCS | $77.5K | 3 |
| MOXIFLOXACIN (AS HYDROCHLORIDE) 0.5% W/V | $50.0K | 1 |
| MOXI MAC ( (Moxifloxacin Ophthalmic Solu | $50.0K | 1 |
| MOXI MAC(MOXIFLOXACIN OPHTHALMIC SOLUTIO | $50.0K | 1 |
| MICROMOX EYE DROPS (MOXIFLOXACIN OPHTHAL | $50.0K | 1 |
| ACTIFLOX MOXIFLOXACIN TABLETS 400MG 5X1X5'SQTY- 7734.00019DRAWBACK | $50.0K | 1 |
Micro Labs Limited exports 60 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MOXI MAC (MOXIFLOXACIN OPHTHALMIC SOLUTI with 5 shipments worth $195.4K.
Regulatory Requirements: Exporting Moxifloxacin to Key Markets
What Micro Labs Limited must comply with to export Moxifloxacin to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Moxifloxacin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MSN LABORATORIES PRIVATE LIMITED | $2.3M | 89 | 13 | $25.9K |
| 4 | MICRO LABS LIMITED ★ | $2.3M | 86 | 14 | $26.5K |
| 3 | EUGIA PHARMA SPECIALITIES LIMITED | $1.9M | 39 | 1 | $50.0K |
| 5 | AJANTA PHARMA LIMITED | $1.4M | 112 | 11 | $12.4K |
Micro Labs Limited ranks #4 among 336 Indian Moxifloxacin exporters. Average shipment value of $26.5K compared to the market average of $42.4K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.
Which Indian Ports Ship Moxifloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 311 | 12.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 263 | 10.9% |
| DELHI AIR CARGO ACC (INDEL4) | 152 | 6.3% |
| DELHI AIR | 132 | 5.5% |
| NHAVA SHEVA SEA (INNSA1) | 126 | 5.2% |
| Bombay Air | 119 | 4.9% |
| CHENNAI AIR | 111 | 4.6% |
| CHENNAI AIR CARGO ACC (INMAA4) | 93 | 3.9% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Moxifloxacin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Moxifloxacin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Moxifloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 91 individual customs records matching Micro Labs Limited exporting Moxifloxacin, covering 60 formulations to 15 countries via 31 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Moxifloxacin Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Moxifloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Moxifloxacin Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Moxifloxacin. For current shipment-level data, contact TransData Nexus.